Actionable news
All posts from Actionable news
Actionable news in ABC: AMERISOURCEBERGEN Corp,

Entry into a Material Definitive

Term Loan Credit Agreement

On November13, 2015, AmerisourceBergen Corporation (the Company) entered into a term loan credit agreement (the Term Loan Credit Agreement) with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto.The Term Loan Credit Agreement provides for a senior unsecured term loan of $1.0 billion (the Term Loan) that matures on November13, 2020 (the Maturity Date).The Company will use the proceeds of the Term Loan to repay funding sources used to finance a portion of the cash consideration paid in connection with the acquisition of PharMEDium Healthcare Holdings,Inc., a Delaware corporation. As previously announced in the Companys Current Report on Form8-K filed on November6, 2015, the acquisition of PharMEDium Healthc are Holdings,Inc. was completed on November6, 2015.

Pursuant to the Term Loan Credit Agreement, the Company is required to make a principal repayment of $25 million on the last business day of each March, June, Septemberand December, commencing in March2016. The remaining unpaid principal amount of the Term Loan is due on the Maturity Date.The Term Loan will bear interest at a rate equal either to an alternate base rate, plus an applicable rate, or a London interbank offered rate (LIBOR), plus an applicable rate, in each case, as determined in accordance with the provisions of the Term Loan Credit Agreement.The applicable rate will be based on the public debt ratings of the Company by Standard& Poors Ratings Services, Moodys Investors Service,Inc. and Fitch,Inc. and ranges from 0 basis points to 25 basis points over an alternate base rate or 75 basis points to 125 basis points over LIBOR, as applicable. The Company has the right to prepay the Term Loan at any time, in whole or in part and without premium or penalty (other than, if applicable, any breakage costs), provided that any such prepayment is in a minimum amount of $5 million. The Term Loan Credit Agreement contains certain affirmative and negative covenants, including a financial leverage ratio, and includes limitations on, among other things, indebtedness of subsidiaries, liens, fundamental changes and asset sales.The Term Loan Credit Agreement also contains certain representations, warranties and events of default (which are, in some cases, subject to certain exceptions, thresholds and grace periods) including, but not limited to, non-payment of principal and interest, failure to perform or observe covenants, breaches of representations and warranties and certain bankruptcy-related events.

The foregoing description of the Term Loan Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the Term Loan Credit Agreement, which is filed as Exhibit10.1 to this Current Report on Form8-K and incorporated by reference herein.

Multi-Currency Revolving Credit Facility

On November13, 2015, the Company and its subsidiaries AmerisourceBergen Specialty Group Canada Corporation,Innomar Strategies Inc. and BP Pharmaceuticals Laboratories Company entered into a Fifth Amendment and Restatement Agreement (the Amendment Agreement) to amend and restate the Credit Agreement, dated as of March18, 2011, as...